Supriya Lifescience moves higher on aiming up to Rs 1,600 crore revenue in next three years

17 Dec 2025 Evaluate

Supriya Lifescience is currently trading at Rs. 737.00, up by 5.85 points or 0.80% from its previous closing of Rs. 731.15 on the BSE.

The scrip opened at Rs. 726.35 and has touched a high and low of Rs. 737.20 and Rs. 721.40 respectively. So far 1349 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 841.70 on 03-Apr-2025 and a 52 week low of Rs. 556.85 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 748.90 and Rs. 709.85 respectively. The current market cap of the company is Rs. 5892.55 crore.

The promoters holding in the company stood at 68.30%, while Institutions and Non-Institutions held 10.68% and 21.02% respectively..

Supriya Lifescience is eyeing up to Rs 1,600 crore revenue from its Lote MIDC in Ratnagiri and Ambernath facilities in the next three years. The company's Patalganga facility will take 2.5-3 years to become operational.

The company had a capex of Rs 160 crore for setting up its Ambernath facility, and Rs 350 crore for the Patalganga unit, which will be spent in a phased manner.

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.

Supriya Lifescience Share Price

736.00 4.85 (0.66%)
17-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.95
Dr. Reddys Lab 1271.00
Cipla 1497.45
Zydus Lifesciences 917.85
Lupin 2109.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×